Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_assertion type Assertion NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_head.
- NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_assertion description "[Degradation of BCR-ABL oncoproteins by heat shock protein 90 (Hsp90) inhibitors in chronic myelogenous leukemia is expected to overcome resistance to ABL tyrosine kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_provenance.
- NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_assertion evidence source_evidence_literature NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_provenance.
- NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_assertion SIO_000772 20675402 NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_provenance.
- NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_assertion wasDerivedFrom befree-2016 NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_provenance.
- NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_assertion wasGeneratedBy ECO_0000203 NP829855.RAht3-DL5fq_Lv5kVtezeX4JhkgVWsGAzNL60AhsFbJ_E130_provenance.